{"id":2574,"date":"2020-11-24T10:43:35","date_gmt":"2020-11-24T09:43:35","guid":{"rendered":"https:\/\/www.celltrend.de\/?p=2574"},"modified":"2020-11-24T10:43:35","modified_gmt":"2020-11-24T09:43:35","slug":"new-us-patent-for-cfs","status":"publish","type":"post","link":"https:\/\/www.celltrend.de\/en\/new-us-patent-for-cfs\/","title":{"rendered":"New US-patent for CFS"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2572\" src=\"https:\/\/www.celltrend.de\/wp-content\/uploads\/2020\/11\/Scan_0007-300x214.jpg\" alt=\"\" width=\"300\" height=\"214\" srcset=\"https:\/\/www.celltrend.de\/wp-content\/uploads\/2020\/11\/Scan_0007-300x214.jpg 300w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2020\/11\/Scan_0007-1024x730.jpg 1024w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2020\/11\/Scan_0007-150x107.jpg 150w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2020\/11\/Scan_0007-768x548.jpg 768w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2020\/11\/Scan_0007.jpg 1397w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>The current patent covers the test developed by us in cooperation with the Charit\u00e9 Berlin, AG Scheibenbogen, for the quantitative determination of antibodies directed against the \u00df-adrenergic receptor. A high antibody titer is an indication of the presence of chronic fatigue syndrome (CFS) and thus plays a decisive role in its diagnosis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The current patent covers the test developed by us in cooperation with the Charit\u00e9 Berlin, AG Scheibenbogen, for the quantitative determination of antibodies directed against the \u00df-adrenergic receptor. A high antibody titer is an indication of the presence of chronic fatigue syndrome (CFS) and thus plays a decisive role in its diagnosis.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"yst_prominent_words":[],"class_list":["post-2574","post","type-post","status-publish","format-standard","hentry","category-news-en","category-9","description-off"],"_links":{"self":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/2574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/comments?post=2574"}],"version-history":[{"count":1,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/2574\/revisions"}],"predecessor-version":[{"id":2575,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/2574\/revisions\/2575"}],"wp:attachment":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/media?parent=2574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/categories?post=2574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/tags?post=2574"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/yst_prominent_words?post=2574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}